study
-
Top Stories
Sawbones® and Numalogics Announce Orthopedic Computational Model Validation & Commercial Partnership
Seattle, Washington – Montreal, Canada, May 17, 2023, /OrthosSpineNews/ – Pacific Research Laboratories, Inc., the parent company to Sawbones® and…
Read More » -
Sports Medicine
Miach Orthopaedics Launches BEAR® Implant Registry Study
Bridge Registry to Track Outcomes Up to Two Years WESTBOROUGH, Mass.–(BUSINESS WIRE)–Miach Orthopaedics, Inc., a privately held company dedicated to…
Read More » -
Recon
Exactech Humeral Reconstruction Prosthesis Two-Year Patient Outcomes Demonstrate Significant Improvements in Pain and Range of Motion, No Cases of Humeral Loosening
Exactech Humeral Reconstruction Prosthesis Two-Year Patient Outcomes Demonstrate Significant Improvements in Pain and Range of Motion, No Cases of Humeral…
Read More » -
Recon
New Exactech Knee Research Demonstrates Ability to Achieve Balanced Results with Short Learning Curve Using Newton™ Technology
GAINESVILLE, FL., April 26, 2023 –(BUSINESS WIRE)–Exactech, a developer and producer of innovative implants, instrumentation, and smart technologies for joint…
Read More » -
Spine
Life Spine Releases Published Article on the Effect of Expandable Versus Static Lordotic Interbody Implants in Minimally Invasive Spine Surgery
HUNTLEY, Ill., April 18, 2023– (BUSINESS WIRE)— Life Spine, a medical device company that designs, develops, manufactures and markets products…
Read More » -
Spine
Aurora Spine Receives IRB Multi-Site Selection Approval for its DEXA-C™ Cervical Interbody System
Carlsbad, Calif., April 04, 2023 (GLOBE NEWSWIRE) — Aurora Spine Corporation (“Aurora Spine” or the “Company”) (TSXV:ASG) (OTCQB:ASAPF), a designer…
Read More » -
Spine
InVivo Therapeutics Announces Topline Data from Pivotal INSPIRE 2.0 Study in Acute Spinal Cord Injury
Study did not achieve primary endpoint of defined improvement on standard impairment scaleInVivo to evaluate full data set and strategic…
Read More » -
Spine
Stratus® Medical announces first patient enrolled in important double-blinded, randomized, comparative trial comparing the Nimbus® radiofrequency ablation device to conventional radiofrequency ablation for the treatment of Sacroiliac Joint pain
MAGNOLIA, Texas, March 9, 2023 /OrthoSpineNews/ — Stratus® Medical, a company focused on advancing radiofrequency (RF) ablation treatment for pain, and the University…
Read More » -
Spine
Study: Intraoperative 3-D Imaging Can Improve Accuracy of Pedicle Screw Placement in Spine Surgery
LAS VEGAS, March 7, 2023 /PRNewswire/ — A study at Hospital for Special Surgery (HSS) found that intraoperative three-dimensional (3D) imaging was…
Read More » -
Recon
Research Published in JSES Indicates that the Catalyst™ CSR Total Shoulder System Outperforms Traditional Stemmed Implants
March 6, 2023 NAPLES, Fla.–(BUSINESS WIRE)– Catalyst OrthoScience Inc. (Catalyst), a medical device company focused on the upper extremity orthopedics market,…
Read More » -
Recon
Smith+Nephew’s VISIONAIRE™ Patient-Specific Instrumentation shown to improve outcome measures for total knee arthroplasty compared with conventional instrumentation
LONDON, March 6, 2023 /PRNewswire/ — Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces a systemic literature review and meta-analysis1 of its VISIONAIRE…
Read More » -
Spine
Aurora Spine Receives IRB Approval To Commence Multicenter Study for its DEXA-C™ Cervical Interbody System
CARLSBAD, Calif., March 02, 2023 (GLOBE NEWSWIRE) — Aurora Spine Corporation (“Aurora Spine” or the “Company”) (TSXV: ASG) (OTCQB: ASAPF),…
Read More » -
Spine
DiscGenics Announces Positive Two-Year Clinical Data from Study of Discogenic Progenitor Cell Therapy for Degenerative Disc Disease
Discogenic progenitor cell therapy safely increased disc volume and provided rapid, durable improvements in low back pain, function, quality of…
Read More » -
Extremities
UAT Group Subsidiary, Ossifix Orthopedics Begins Comparative Study
Tampa, FL, Jan. 20, 2023 (GLOBE NEWSWIRE) — Umbra Applied Technologies Group, Inc. (OTC Pink: UATG) (UAT Group) announce today…
Read More » -
Recon
Hip Innovation Technology Announces Initiation of FDA Approved Investigational Device Exemption Study
First U.S. Implantation of its Reverse Hip Replacement System for the Treatment of Total Hip Arthroplasty Completed BOCA RATON, Fla., Jan.…
Read More »